Thomas J. Smith
Principal investigator.
Medtech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$15.2MFederal grants as PI21 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
21 awards · $15.2M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 17, 2026 | NIH | SBIR Phase II Long-acting Injectable Brexpiprazole for Agitation in Alzheimer's Dementia | $1.0M | AURITEC PHARMACEUTICALS, INC. |
| Aug 18, 2025 | NIH | SBIR Phase II IND-enabling Preclinical Development of a Sustained-release Pritelivir Intravaginal ring for the Treatment and Prophylaxis of Genital Herpes | $1.0M | AURITEC PHARMACEUTICALS, INC. |
| Jul 24, 2024 | NIH | SBIR Phase II IND-enabling Preclinical Development of a Sustained-release Pritelivir Intravaginal ring for the Treatment and Prophylaxis of Genital Herpes | $1.0M | AURITEC PHARMACEUTICALS, INC. |
| Sep 14, 2023 | NIH | SBIR Phase II IND-enabling Preclinical Development of a Sustained-release Pritelivir Intravaginal ring for the Treatment and Prophylaxis of Genital Herpes | $1.0M | AURITEC PHARMACEUTICALS, INC. |
| Jun 22, 2023 | NIH | SBIR Phase II Long-acting injectable tacrolimus for chronic immunosuppression | $1.0M | AURITEC PHARMACEUTICALS, INC. |
| Aug 17, 2022 | NIH | SBIR Phase II Longer-acting intravaginal formulation of buprenorphine | $845K | AURITEC PHARMACEUTICALS, INC. |
| Jul 8, 2022 | NIH | SBIR Phase II Long-acting injectable tacrolimus for chronic immunosuppression | $1.0M | AURITEC PHARMACEUTICALS, INC. |
| Aug 20, 2021 | NIH | SBIR Phase II Longer-acting intravaginal formulation of buprenorphine | $845K | AURITEC PHARMACEUTICALS, INC. |
| Apr 16, 2021 | NIH | SBIR Phase II I-Corps: Longer-acting intravaginal formulation of buprenorphine | $55K | AURITEC PHARMACEUTICALS, INC. |
| Sep 21, 2020 | NIH | SBIR Phase II Longer-acting intravaginal formulation of buprenorphine | $254K | AURITEC PHARMACEUTICALS, INC. |
| Jun 1, 2020 | NIH | SBIR Phase II IND-enabling preclinical development of a system for the multipurpose prevention of HIV and unintended pregnancy | $1000K | AURITEC PHARMACEUTICALS, INC. |
| Feb 28, 2020 | NIH | SBIR Phase II IND-enabling preclinical development of a sustained-release Pritelivir intravaginal ring for the treatment and prophylaxis of Genital Herpes in women | $1.0M | AURITEC PHARMACEUTICALS, INC. |
| Jul 22, 2019 | NIH | SBIR Phase II IND-enabling preclinical development of a system for the multipurpose prevention of HIV and unintended pregnancy | $1000K | AURITEC PHARMACEUTICALS, INC. |
| Apr 3, 2019 | NIH | SBIR Phase II IND-enabling preclinical development of a sustained-release Pritelivir intravaginal ring for the treatment and prophylaxis of Genital Herpes in women | $861K | AURITEC PHARMACEUTICALS, INC. |
| Jan 25, 2018 | NIH | SBIR Phase I Preclinical development of an intravaginal ring for the sustained release of Pritelivir for the treatment and prophylaxis of Genital Herpes in women | $251K | AURITEC PHARMACEUTICALS, INC. |
| Sep 1, 2017 | NIH | SBIR Phase I Preclinical development of an intravaginal ring for the sustained-release of octreotide for the treatment of acromegaly. | $225K | AURITEC PHARMACEUTICALS, INC. |
| Jun 30, 2016 | NIH | SBIR Phase II Automation of GMP manufacturing of HIV microbicide rings | $698K | AURITEC PHARMACEUTICALS, INC. |
| Mar 29, 2016 | NIH | SBIR Phase II Clinical safety and pharmacokinetic studies of intravaginal rings releasing multiple antiretrovirals | $637K | AURITEC PHARMACEUTICALS, INC. |
| Oct 27, 2015 | NIH | SBIR Phase II Automation of GMP manufacturing of HIV microbicide rings | $447K | AURITEC PHARMACEUTICALS, INC. |
| Sep 24, 2015 | NIH | SBIR Phase II Automation of GMP manufacturing of HIV microbicide rings | $337K | AURITEC PHARMACEUTICALS, INC. |
| Apr 6, 2015 | NIH | SBIR Phase II Clinical safety and pharmacokinetic studies of intravaginal rings releasing multiple antiretrovirals | $664K | AURITEC PHARMACEUTICALS, INC. |
Peer ranks
Federal funding#24
Awards as PI#21
Patents#505
Companies
- AURITEC PHARMACEUTICALS, INC.Linked by awards · Medtech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.